(Q43629197)
Statements
A randomized, double-blind, placebo-controlled, ascending-dose tolerability and safety study of remacemide as adjuvant therapy in Parkinson's disease with response fluctuations (English)
J A Cooper
T A Holdich
TREMOR Study Group